CHRS Coherus BioSciences, Inc.

NASDAQ
$0.41

Coherus BioSciences, Inc. (CHRS) Earnings News

Earnings press releases, previews and reviews for Coherus BioSciences, Inc. (CHRS), newest first. Our most recent is review: Coherus Misses on Both Lines as Loqtorzi Stalls, Guidance Is Cut and a Going-Concern Warning Overshadows an Esophageal Signal.